ORAL DOSING WITH THE GP-IIB IIIA RECEPTOR ANTAGONIST SC-54684A INHIBITS THE FORMATION OF PLATELET-RICH THROMBI ON DAMAGED CANINE AORTA MOUNTED IN AN EX-VIVO PERFUSION CHAMBER/
Da. Baron et al., ORAL DOSING WITH THE GP-IIB IIIA RECEPTOR ANTAGONIST SC-54684A INHIBITS THE FORMATION OF PLATELET-RICH THROMBI ON DAMAGED CANINE AORTA MOUNTED IN AN EX-VIVO PERFUSION CHAMBER/, Thrombosis and haemostasis, 73(6), 1995, pp. 1332-1332